<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xml:lang="EN" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="editorial">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Hum. Neurosci.</journal-id>
<journal-title>Frontiers in Human Neuroscience</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Hum. Neurosci.</abbrev-journal-title>
<issn pub-type="epub">1662-5161</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fnhum.2024.1476971</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Human Neuroscience</subject>
<subj-group>
<subject>Editorial</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Editorial: The cognitive neuroscience of aging: where we are and where we are going</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name><surname>d&#x00027;Oleire Uquillas</surname> <given-names>Federico</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="corresp" rid="c001"><sup>&#x0002A;</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/202919/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/visualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Falck</surname> <given-names>Ryan S.</given-names></name>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<xref ref-type="aff" rid="aff3"><sup>3</sup></xref>
<xref ref-type="aff" rid="aff4"><sup>4</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/195665/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Oken</surname> <given-names>Barry S.</given-names></name>
<xref ref-type="aff" rid="aff5"><sup>5</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/467657/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
</contrib-group>
<aff id="aff1"><sup>1</sup><institution>Princeton Neuroscience Institute, Princeton University</institution>, <addr-line>Princeton, NJ</addr-line>, <country>United States</country></aff>
<aff id="aff2"><sup>2</sup><institution>School of Biomedical Engineering, University of British Columbia</institution>, <addr-line>Vancouver, BC</addr-line>, <country>Canada</country></aff>
<aff id="aff3"><sup>3</sup><institution>Vancouver Coastal Health Research Institute, Faculty of Medicine, University of British Columbia</institution>, <addr-line>Vancouver, BC</addr-line>, <country>Canada</country></aff>
<aff id="aff4"><sup>4</sup><institution>Rehabilitation and Technology (SMART) at Vancouver Coastal Health</institution>, <addr-line>Vancouver, BC</addr-line>, <country>Canada</country></aff>
<aff id="aff5"><sup>5</sup><institution>Departments of Neurology and Behavioral Neuroscience, Oregon Health &#x00026; Science University</institution>, <addr-line>Portland, OR</addr-line>, <country>United States</country></aff>
<author-notes>
<fn fn-type="edited-by"><p>Edited and reviewed by: Lutz J&#x000E4;ncke, University of Zurich, Switzerland</p></fn>
<corresp id="c001">&#x0002A;Correspondence: Federico d&#x00027;Oleire Uquillas <email>uquillas&#x00040;princeton.edu</email></corresp>
</author-notes>
<pub-date pub-type="epub">
<day>28</day>
<month>08</month>
<year>2024</year>
</pub-date>
<pub-date pub-type="collection">
<year>2024</year>
</pub-date>
<volume>18</volume>
<elocation-id>1476971</elocation-id>
<history>
<date date-type="received">
<day>06</day>
<month>08</month>
<year>2024</year>
</date>
<date date-type="accepted">
<day>15</day>
<month>08</month>
<year>2024</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#x000A9; 2024 d&#x00027;Oleire Uquillas, Falck and Oken.</copyright-statement>
<copyright-year>2024</copyright-year>
<copyright-holder>d&#x00027;Oleire Uquillas, Falck and Oken</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/"><p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p></license>
</permissions>
<related-article id="RA1" related-article-type="commentary-article" xlink:href="https://www.frontiersin.org/research-topics/54962/the-cognitive-neuroscience-of-aging-where-we-are-and-where-we-are-going" ext-link-type="uri">Editorial on the Research Topic <article-title>The cognitive neuroscience of aging: where we are and where we are going</article-title></related-article>
<kwd-group>
<kwd>cognitive function</kwd>
<kwd>aging</kwd>
<kwd>biomarkers and prevention</kwd>
<kwd>neurodiversity</kwd>
<kwd>cognitive enhancement</kwd>
</kwd-group>
<counts>
<fig-count count="1"/>
<table-count count="0"/>
<equation-count count="0"/>
<ref-count count="5"/>
<page-count count="3"/>
<word-count count="1619"/>
</counts>
<custom-meta-wrap>
<custom-meta>
<meta-name>section-at-acceptance</meta-name>
<meta-value>Cognitive Neuroscience</meta-value>
</custom-meta>
</custom-meta-wrap>
</article-meta>
</front>
<body>
<sec sec-type="intro" id="s1">
<title>Introduction</title>
<p>As our lifespan increases, so does our risk for cognitive decline and disorders associated with aging, such as Alzheimer&#x00027;s disease (AD) dementia. More than 50 million people were living with dementia in 2020, a number that could rise to 139 million by 2050, exceeding $1.3 trillion dollars in dementia-related costs.<xref ref-type="fn" rid="fn0001"><sup>1</sup></xref> Given such societal and economic impact, and that the global population of adults older than 70 years old continues to outpace the growth of younger adults (Garmany et al., <xref ref-type="bibr" rid="B3">2021</xref>), there is an increasing need for effective interventions targeting aging and cognitive impairment in these populations. This involves better understanding complementary markers of resilience across genetic, social, and biological constructs. To that end, here we review a set of recent findings that together provide an overview of the current state of the field and posit potential avenues for continuing to elucidate the cognitive neuroscience of aging.</p></sec>
<sec id="s2">
<title>Social factors and cognitive health</title>
<p><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fnhum.2024.1380002">Oken et al.</ext-link> highlight the critical need for interventions to address the insidious effects of loneliness and social isolation on cognitive health. Mid-life subjective feelings of loneliness have been shown to correlate with cognitive decline later in life (Akhter-Khan et al., <xref ref-type="bibr" rid="B1">2021</xref>), dementia risk, and brain pathology (d&#x00027;Oleire Uquillas et al., <xref ref-type="bibr" rid="B2">2018</xref>), and its contribution to AD risk is even comparable to having a single APOE4 gene. Moreover, <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fnhum.2024.1380002">Oken et al.</ext-link> provide evidence that loneliness contributes to cognitive impairment independently of Alzheimer&#x00027;s pathology or other established risk factors. Their review underscores the importance of promoting social engagement as a strategy to maintain cognitive health in older adults.</p>
</sec>
<sec id="s3">
<title>Cognitive reserve a protective factor</title>
<p>Factors that provide resilience against cognitive decline can be conceptualized as cognitive reserve (CR) (Stern et al., <xref ref-type="bibr" rid="B5">2019</xref>). CR is pivotal in offsetting cognitive decline by allowing some individuals to maintain cognitive function despite age-related changes and brain injury (Stern et al., <xref ref-type="bibr" rid="B5">2019</xref>). <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fnagi.2023.1327388">Borchers et al.</ext-link> have further explored this phenomena by investigating how the CR markers of IQ and educational attainment are related to postoperative neurocognitive disorders (PNDs). Their study demonstrates the role of CR in mitigating cognitive decline after surgery, but also notes the challenges in using CR markers, such as variability in preoperative cognitive status, and difficulties in standardizing anesthesia and postoperative treatment.</p></sec>
<sec id="s4">
<title>Predicting cognitive decline</title>
<p><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fnagi.2024.1336008">Curiel Cid et al.</ext-link> investigated psychometric predictors of progression in amnestic mild cognitive impairment (MCI) and identified proactive semantic interference (PSI) as an early detection marker of progression. Their findings suggest that individuals who exhibit higher levels of PSI may be at increased risk of developing dementia. By elucidating these predictive factors, <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fnagi.2024.1336008">Curiel Cid et al.</ext-link> contribute to a deeper understanding of the transition from MCI to dementia, and pave the way for more effective clinical interventions. <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fnagi.2024.1336008">Curiel Cid et al.</ext-link> also address limitations in their study on MCI progression, particularly pointing at the need for broader participant inclusion and longer follow-up periods. These findings align with broader themes addressed in the article collection &#x0201C;Longitudinal Aging Research: Cognition, Behavior and Neuroscience,&#x0201D; which highlights the importance of better understanding cognitive decline and aging trajectories: <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/research-topics/11503/longitudinal-aging-research-cognition-behavior-and-neuroscience">https://www.frontiersin.org/research-topics/11503/longitudinal-aging-research-cognition-behavior-and-neuroscience</ext-link> (J&#x000E4;ncke et al., <xref ref-type="bibr" rid="B4">2022</xref>). Further, implementing routine cognitive testing during medical check-ups to establish baselines and detect early shifts in cognitive performance, before symptoms fully manifest, may significantly impact individual outcomes.</p></sec>
<sec id="s5">
<title>Enhancing cognitive function through technology</title>
<p>In a usability study of neurotechnology for cognitive enhancement, <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fnhum.2023.1310375">Stramba-Badiale et al.</ext-link> demonstrated in MCI patients how technology can be harnessed to improve spatial navigation skills, a critical aspect of daily living often impaired in MCI and early dementia. By enhancing cognitive function through virtual reality (VR), they also raise important considerations regarding the accessibility and usability of VR technologies in clinical settings and beyond (e.g., insurance coverage, subsidies, etc.). Their findings emphasize the need for the development of policy that ensures equitable access to such emerging technologies. Overall, their findings suggest that user-friendly digital tools can be an effective aid in cognitive rehabilitation, and offer a promising target for non-pharmacological interventions in cognitive aging.</p></sec>
<sec id="s6">
<title>Neurodiversity and aging</title>
<p>In their study of age-related differences in autistic individuals in the intrinsic connectivity of the hippocampus to the ventral lobe, circuits crucial for memory and spatial navigation, <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fnhum.2024.1394706">Chen et al.</ext-link> reveal that the aging process may look different across the neurodivergent spectrum. They call for inclusive research that considers diverse aging experiences in neurodiverse populations, and emphasize the importance of developing interventions for aging and cognitive decline that are tailored to meet the needs of neurodiverse individuals.</p></sec>
<sec id="s7">
<title>Biomarkers in cognitive disorders</title>
<p>Understanding the neurobiological underpinnings of disease and age-related cognitive decline is essential for developing diagnostics and interventions. The review by <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fnhum.2024.1392519">Liu et al.</ext-link>, discusses the role of neuron-specific enolase (NSE), a glycolytic enzyme found in neurons that is associated with neuronal damage and compromised cognitive function. NSE is emerging as a marker of brain health that may help facilitate the monitoring of cognitive decline and disease progression.</p></sec>
<sec sec-type="conclusions" id="s8">
<title>Conclusion</title>
<p>Promoting interdisciplinary collaborations and fostering equitable access to healthcare is essential for translating research findings into effective clinical practice and policy. Bridging gaps between neuroscience, psychology, public health, and geriatrics, also helps accelerate the development of therapeutic approaches for cognitive aging. In clinical settings, the integration of diverse reserve markers appears crucial, such as assessing social engagement, including the quality and quantity of social interactions. The figure above highlights other important reserve and aging factors not discussed here that may play a role in maintaining cognition in the face of increasing age, such as sleep, and dietary factors (<xref ref-type="fig" rid="F1">Figure 1</xref>). As we gain a more nuanced understanding of cognitive aging, we ultimately improve the quality of life for aging populations.</p>
<fig id="F1" position="float">
<label>Figure 1</label>
<caption><p>This figure highlights additional factors not directly discussed in the main text that may contribute to cognitive resilience and aging. A better understanding of how these may interact with established reserve mechanisms in supporting cognitive health in later life is crucial.</p></caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fnhum-18-1476971-g0001.tif"/>
</fig>
</sec>
</body>
<back>
<sec sec-type="author-contributions" id="s9">
<title>Author contributions</title>
<p>FdU: Conceptualization, Visualization, Writing &#x02013; original draft, Writing &#x02013; review &#x00026; editing. RF: Conceptualization, Writing &#x02013; original draft, Writing &#x02013; review &#x00026; editing. BO: Writing &#x02013; original draft, Writing &#x02013; review &#x00026; editing.</p>
</sec>
<sec sec-type="funding-information" id="s10">
<title>Funding</title>
<p>The author(s) declare financial support was received for the research, authorship, and/or publication of this article. Funding support was received for BO, grant number: NIH P30 AG066518.</p>
</sec>
<sec sec-type="COI-statement" id="conf1">
<title>Conflict of interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The author(s) declared that they were an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision.</p>
</sec>
<sec sec-type="disclaimer" id="s11">
<title>Publisher&#x00027;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<fn-group>
<fn id="fn0001"><p><sup>1</sup>Alzheimer&#x00027;s Disease International. Available at: <ext-link ext-link-type="uri" xlink:href="https://www.alzint.org/about/dementia-facts-figures/dementia-statistics/">https://www.alzint.org/about/dementia-facts-figures/dementia-statistics/</ext-link>.</p></fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="B1">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Akhter-Khan</surname> <given-names>S. C.</given-names></name> <name><surname>Tao</surname> <given-names>Q.</given-names></name> <name><surname>Ang</surname> <given-names>T. F. A.</given-names></name> <name><surname>Itchapurapu</surname> <given-names>I. S.</given-names></name> <name><surname>Alosco</surname> <given-names>M. L.</given-names></name> <name><surname>Mez</surname> <given-names>J.</given-names></name> <etal/></person-group>. (<year>2021</year>). <article-title>Associations of loneliness with risk of Alzheimer&#x00027;s disease dementia in the Framingham heart study</article-title>. <source>Alzheimers Dement.</source> <volume>17</volume>, <fpage>1619</fpage>&#x02013;<lpage>1627</lpage>. <pub-id pub-id-type="doi">10.1002/alz.12327</pub-id><pub-id pub-id-type="pmid">33760348</pub-id></citation></ref>
<ref id="B2">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>d&#x00027;Oleire Uquillas</surname> <given-names>F.</given-names></name> <name><surname>Jacobs</surname> <given-names>H. I. L.</given-names></name> <name><surname>Biddle</surname> <given-names>K. D.</given-names></name> <name><surname>Properzi</surname> <given-names>M.</given-names></name> <name><surname>Hanseeuw</surname> <given-names>B.</given-names></name> <name><surname>Schultz</surname> <given-names>A. P.</given-names></name> <etal/></person-group>. (<year>2018</year>). <article-title>Regional tau pathology and loneliness in cognitively normal older adults</article-title>. <source>Transl. Psychiatry</source> <volume>8</volume>:<fpage>282</fpage>. <pub-id pub-id-type="doi">10.1038/s41398-018-0345-x</pub-id><pub-id pub-id-type="pmid">30563962</pub-id></citation></ref>
<ref id="B3">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Garmany</surname> <given-names>A.</given-names></name> <name><surname>Yamada</surname> <given-names>S.</given-names></name> <name><surname>Terzic</surname> <given-names>A.</given-names></name></person-group> (<year>2021</year>). <article-title>Longevity leap: mind the healthspan gap</article-title>. <source>NPJ Regener. Med.</source> <volume>57</volume>, <fpage>1</fpage>&#x02013;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1038/s41536-021-00169-5</pub-id><pub-id pub-id-type="pmid">34556664</pub-id></citation></ref>
<ref id="B4">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>J&#x000E4;ncke</surname> <given-names>L.</given-names></name> <name><surname>Martin</surname> <given-names>M.</given-names></name> <name><surname>R&#x000F6;cke</surname> <given-names>C.</given-names></name> <name><surname>M&#x000E9;rillat</surname> <given-names>S.</given-names></name></person-group> (<year>2022</year>). <article-title>Editorial: Longitudinal aging research: cognition, behavior and neuroscience</article-title>. <source>Front. Hum. Neurosci</source>. <volume>16</volume>:<fpage>1002560</fpage>. <pub-id pub-id-type="doi">10.3389/fnhum.2022.1002560</pub-id><pub-id pub-id-type="pmid">36310846</pub-id></citation></ref>
<ref id="B5">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Stern</surname> <given-names>Y.</given-names></name> <name><surname>Barnes</surname> <given-names>C.A.</given-names></name> <name><surname>Grady</surname> <given-names>C.</given-names></name> <name><surname>Jones</surname> <given-names>R.N.</given-names></name> <name><surname>Raz</surname> <given-names>N.</given-names></name></person-group> (<year>2019</year>). <article-title>Brain reserve, cognitive reserve, compensation, and maintenance: operationalization, validity, and mechanisms of cognitive resilience</article-title>. <source>Neurobiol. Aging</source> <volume>83</volume>, <fpage>124</fpage>&#x02013;<lpage>129</lpage>. <pub-id pub-id-type="doi">10.1016/j.neurobiolaging.2019.03.022</pub-id><pub-id pub-id-type="pmid">31732015</pub-id></citation></ref>
</ref-list>
</back>
</article>